Search Results - "Haskins, Chris P"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic by Marcus, David J, Zee, Michael L, Davis, Brian J, Haskins, Chris P, Andrews, Mary-Jeanette, Amin, Randa, Henderson-Redmond, Angela N, Mackie, Ken, Czyzyk, Traci A, Morgan, Daniel J

    Published in PloS one (08-08-2016)
    “…Multiple lines of evidence implicate the endocannabinoid signaling system in the modulation of metabolic disease. Genetic or pharmacological inactivation of…”
    Get full text
    Journal Article
  2. 2

    c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner by Henderson-Redmond, Angela N., Nealon, Caitlin M., Davis, Brian J., Yuill, Matthew B., Sepulveda, Diana E., Blanton, Henry L., Piscura, Mary K., Zee, Michael L., Haskins, Chris P., Marcus, David J., Mackie, Ken, Guindon, Josée, Morgan, Daniel J.

    Published in Neuropharmacology (01-03-2020)
    “…Tolerance to the antinociceptive effects of cannabinoids represents a significant limitation to their clinical use in managing chronic pain. Tolerance likely…”
    Get full text
    Journal Article
  3. 3

    Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 by Marcus, David J, Zee, Michael L, Davis, Brian J, Haskins, Chris P, Andrews, Mary-Jeanette, Amin, Randa, Henderson-Redmond, Angela N, Mackie, Ken, Czyzyk, Traci A, Morgan, Daniel J

    Published in PloS one (08-08-2016)
    “…Multiple lines of evidence implicate the endocannabinoid signaling system in the modulation of metabolic disease. Genetic or pharmacological inactivation of…”
    Get full text
    Journal Article